SmithKline Beecham to distribute Trinity's tests:
This article was originally published in Clinica
SmithKline Beecham International is to distribute Trinity Biotech's SeroCard and SalivaCard rapid HIV tests in certain African countries. SmithKline Beecham will purchase an agreed annual quantity of the products from Trinity and will sell the products under its own label. SKB will be responsible for attaining regulatory approvals. If successful, the companies intend to expand the agreement to a broader product offering. Irish company Trinity Biotech manufactures and markets rapid tests for the point of care, over-the-counter and the clinical laboratory markets.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.